Yimin Liu

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Shangyou Zheng · 12 shared papers, 2015–2022 · strength 0.83
   • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
   • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
   • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
2. Quanbo Zhou · 12 shared papers, 2015–2022 · strength 0.79
   • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
   • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
   • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
3. Huilin Ye · 11 shared papers, 2015–2022 · strength 0.75
   • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
   • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
   • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
4. Xiaohui Zhao · 10 shared papers, 2015–2022 · strength 0.65
   • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
   • Paper Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer pati… DOI 10.3748/wjg.v25.i1.138↗
   • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
5. Zhihua Li · 7 shared papers, 2015–2021 · strength 0.56
   • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
   • Paper Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer pati… DOI 10.3748/wjg.v25.i1.138↗
   • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
6. Zhiqiang Fu · 9 shared papers, 2015–2018 · strength 0.49
   • Paper Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic du… DOI 10.1038/s41419-018-0486-0↗
   • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
   • Paper FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-017-0052-1↗
7. Guolin Li · 6 shared papers, 2016–2021 · strength 0.46
   • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
   • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
   • Paper Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic du… DOI 10.1038/s41419-018-0486-0↗
8. Rufu Chen · 8 shared papers, 2015–2018 · strength 0.43
   • Paper Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic du… DOI 10.1038/s41419-018-0486-0↗
   • Paper FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-017-0052-1↗
   • Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
9. Wenchao Gao · 8 shared papers, 2015–2022 · strength 0.43
   • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
   • Paper The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expre… DOI 10.1007/s13277-015-4234-0↗
   • Paper Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by r… DOI 10.1016/j.canlet.2015.12.010↗
10. Lusheng Wei · 5 shared papers, 2017–2021 · strength 0.41
    • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
    • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
    • Paper Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic du… DOI 10.1038/s41419-018-0486-0↗
11. Wenzhu Li · 6 shared papers, 2015–2022 · strength 0.40
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
    • Paper FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-017-0052-1↗
12. Yingxue Wang · 6 shared papers, 2015–2022 · strength 0.40
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. DOI 10.1038/s41419-017-0052-1↗
    • Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
13. Zhihua Li · 6 shared papers, 2015–2022 · strength 0.38
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
    • Paper The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expre… DOI 10.1007/s13277-015-4234-0↗
14. Yuming Luo · 4 shared papers, 2016–2022 · strength 0.30
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
    • Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗
15. Rufu Chen · 4 shared papers, 2015–2021 · strength 0.30
    • Paper Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway i… DOI 10.1038/s41419-021-03420-5↗
    • Paper Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic… DOI 10.1038/s41419-018-1104-x↗
    • Paper Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review an… DOI 10.1097/md.0000000000001345↗
16. Huimou Chen · 4 shared papers, 2015–2022 · strength 0.26
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expre… DOI 10.1007/s13277-015-4234-0↗
    • Paper Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by r… DOI 10.1016/j.canlet.2015.12.010↗
17. Langping Tan · 4 shared papers, 2015–2022 · strength 0.25
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by r… DOI 10.1016/j.canlet.2015.12.010↗
    • Paper Metabolic phenotypes in pancreatic cancer. DOI 10.1371/journal.pone.0115153↗
18. Yanhui Jiang · 3 shared papers, 2016–2018 · strength 0.17
    • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
    • Paper The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expre… DOI 10.1007/s13277-015-4234-0↗
    • Paper Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by r… DOI 10.1016/j.canlet.2015.12.010↗
19. Rufu Chen · 2 shared papers, 2015–2022 · strength 0.16
    • Paper Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases ce… DOI 10.1016/j.canlet.2022.215859↗
    • Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
20. Yu Zhou · 3 shared papers, 2015 · strength 0.13
    • Paper Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. DOI 10.18632/oncotarget.5533↗
    • Paper Metabolic phenotypes in pancreatic cancer. DOI 10.1371/journal.pone.0115153↗
    • Paper The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cance… DOI 10.1186/s12967-015-0442-z↗
21. Doudou Li · 2 shared papers, 2015 · strength 0.09
    • Paper Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review an… DOI 10.1097/md.0000000000001345↗
    • Paper Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherap… DOI 10.18632/oncotarget.5150↗
22. Yu Zhou · 2 shared papers, 2015 · strength 0.09
    • Paper Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review an… DOI 10.1097/md.0000000000001345↗
    • Paper Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused b… DOI 10.1007/s00125-014-3481-8↗
23. Min Yu · 2 shared papers, 2015 · strength 0.08
    • Paper Metabolic phenotypes in pancreatic cancer. DOI 10.1371/journal.pone.0115153↗
    • Paper Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused b… DOI 10.1007/s00125-014-3481-8↗
24. Chen Rufu · 1 shared paper, 2018 · strength 0.07
    • Paper Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic… DOI 10.1111/jcmm.13351↗
25. Yue Zhao · 1 shared paper, 2017 · strength 0.06
    • Paper Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer … DOI 10.1038/cddiscovery.2017.4↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.